NSAIDs are efficacious for treatment of acute and chronic pain, yet have the potential for serious adverse events (AEs). The objective of this study was to evaluate the efficacy and safety of investigational, proprietary, lower-dose, submicron particle indomethacin capsules compared with placebo in a study in patients with postsurgical pain.
Pharmacology, Toxicology and Pharmaceutical Science
1
3%
Neuroscience
1
3%
Unknown
15
39%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2014.
All research outputs
#28,639,288
of 34,410,315 outputs
Outputs from Clinical journal of pain
#2,037
of 2,290 outputs
Outputs of similar age
#232,765
of 298,168 outputs
Outputs of similar age from Clinical journal of pain
#25
of 34 outputs
Altmetric has tracked 34,410,315 research outputs across all sources so far. This one is in the 9th percentile – i.e., 9% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,290 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,168 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
